ARTIDIS rapidly diagnoses cancer, detects its aggressiveness and predicts the probability of a patient developing metastases based on the nanomechanical biomarker for cancer. The ARTIDISNET platform combines the nanomechanical biomarker with the patient’s clinical data to guide the best therapy choice for each individual patient.
